In colorectal cancer, elevated cathepsin B and cathepsin L are associated with increased disease metastasis and poorer prognosis (22), while elevated cathepsin S predicts both decreased survival when treated with surgery alone, with potential benefit from adjuvant 5-fluorouracil and folinic acid treatment. Here, CTSL is linked to colorectal cancer.